Institutional investors purchased a net $6.6 million shares of MNKD during the quarter ended March 2013. This may signal that the smart money is gaining interest in this company as the 18.31% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 6.0 Million shares of Mannkind Corp
BLACKROCK FUND ADVISORS Bought 2.2 Million shares of Mannkind Corp
RENAISSANCE TECHNOLOGIES LLC Bought 1.4 Million shares of Mannkind Corp